about
Palbociclib: First CDK4/6 Inhibitor in Clinical Practice for the Treatment of Advanced HR-Positive Breast CancerDo Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study.The safety and efficacy of palbociclib in the treatment of metastatic breast cancer.
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
ABC3 Consensus: Assessment by a German Group of Experts
@ast
ABC3 Consensus: Assessment by a German Group of Experts
@en
type
label
ABC3 Consensus: Assessment by a German Group of Experts
@ast
ABC3 Consensus: Assessment by a German Group of Experts
@en
prefLabel
ABC3 Consensus: Assessment by a German Group of Experts
@ast
ABC3 Consensus: Assessment by a German Group of Experts
@en
P2093
P2860
P356
P1433
P1476
ABC3 Consensus: Assessment by a German Group of Experts
@en
P2093
Christoph Thomssen
Diana Lüftner
Doris Augustin
Eugen Ruckhäberle
Frederik Marmé
Friedrich Overkamp
Hans-Joachim Lück
Johannes Ettl
Lothar Müller
Marc Thill
P2860
P356
10.1159/000443515
P577
2016-01-29T00:00:00Z